Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Wednesday, October 21, 2026

Back to today

From X

@StableBread

Fajasy on X

$ATII now base:0x1a5f7931e5d450c666fd8706300b984fc4aeaba3 -- Forge Nano completed its de-SPAC merger and will list on NASDAQ on October 22, 2026. The merged company will receive $100M from the PIPE investor, who buys 2.97M shares, 7.03M pre-funded warrants (effectively shares), and 15M warrants at $10. An additional warrant reset could add more dilution if the stock is below $10 after six months, with a floor of $7.28 if a $200M debt deal is secured. Over 22 million SPAC shares were redeemed for $238.4M (approx. $10.73/share), leaving only $8.4M in the trust account for the combined company! Not the greatest as this significantly limits the cash available for operations and growth. On the other hand, the company has expanded its Taiwan semiconductor footprint, demonstrated a 1,000:1 coating demo, deeper Samsung SDI ties, a pharma JV with Nanexa, and broke ground on its North Carolina battery gigafactory. Wrote a deep dive here couple months ago btw: https://t.co/XchBCEYQ1q
@orrdavid 3 clicks

David Orr on X

The next 5 years could be an incredible stock picker's market. Long the companies that win from AI efficiencies but whos business is not threatened by AI. Companies who get to fire their lawyers and accountants etc but already have an impossible to beat scale advantage (because AI does not attack that scale advantage). Short the companies that lose from big AI threats. $RSP $SPY $IWM etc could go nowhere for 5 years while half the stocks trade down 70%, half trade up 70%.
@StableBread 1 click

Fajasy on X

$ATII now $NANO... Forge Nano completed its de-SPAC merger and will list on NASDAQ on October 22, 2026. The merged company will receive $100M from the PIPE investor, who buys 2.97M shares, 7.03M pre-funded warrants (effectively shares), and 15M warrants at $10. An additional warrant reset could add more dilution if the stock is below $10 after six months, with a floor of $7.28 if a $200M debt deal is secured. Over 22 million SPAC shares were redeemed for $238.4M (approx. $10.73/share), leaving only $8.4M in the trust account for the combined company! Not the greatest as this significantly limits the cash available for operations and growth. On the other hand, the company has expanded its Taiwan semiconductor footprint, demonstrated a 1,000:1 coating demo, deeper Samsung SDI ties, a pharma JV with Nanexa, and broke ground on its North Carolina battery gigafactory. Wrote a deep dive here couple months ago btw: https://t.co/XchBCEYQ1q
@AsifSuria

Asif Suria on X

"We believe mgmt. wants to make sure it gets credit for that ramp, which could happen by letting the next 1-4 quarters play out." Management at $LION has been deeply entrenched and the company has become an "activist black hole". Carl Icahn's protege Mark Rachesky disappeared into it and it also swallowed our former Treasury Secretary Steven Mnuchin. At least after Mnuchin got involved, we managed to get rid of the dual class structure and Starz $STRZ was spun out. Like @valuedontlie I should have doubled down on Starz instead of $LION. Still long Lionsgate Studios and still willing to be patient but it feels like Feltheimer has perfected the art of moving the goal post.

Investor Letters

All letters

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $79M
Calvin Blissett 10 clicks

Build-A-Bear: A Narrower Path

Build-A-Bear's push into prestuffed toys and broader retail distribution tests brand stretchability, but recent results warrant caution.

BBW $303M
TSOH Investment Research 18 clicks

Twenty Years in the Dark

Tower Properties, $TPRP, went dark after a 2006 squeeze-out cut holders below 300, leaving a Kemper-controlled apartment and office…

TPRP $128M
Orphan REITs 5 clicks

TSOH Weekly Roundup (10/16/2026)

Bumble agreed to a $1.3 billion take-private deal, while Netflix cut about 1,000 jobs and Meta discussed its Muse superintelligence models.

BMBL $783M
TSOH Investment Research 12 clicks
ADCT · long

Adc Therapeutics SA (adct)

ADC Therapeutics centers on ZYNLONTA, an approved CD19-directed antibody-drug conjugate, after shares rose from roughly $4.

ADCT $195M
Value Investors Club 3 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 54 of 245

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

90 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.